223 related articles for article (PubMed ID: 23728936)
41. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
[TBL] [Abstract][Full Text] [Related]
42. In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations.
Dastani Z; Berger C; Langsetmo L; Fu L; Wong BY; Malik S; Goltzman D; Cole DE; Richards JB
J Bone Miner Res; 2014 Feb; 29(2):494-9. PubMed ID: 23857798
[TBL] [Abstract][Full Text] [Related]
43. Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling.
Chun RF; Peercy BE; Adams JS; Hewison M
PLoS One; 2012; 7(1):e30773. PubMed ID: 22292037
[TBL] [Abstract][Full Text] [Related]
44. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
Bosworth CR; Levin G; Robinson-Cohen C; Hoofnagle AN; Ruzinski J; Young B; Schwartz SM; Himmelfarb J; Kestenbaum B; de Boer IH
Kidney Int; 2012 Sep; 82(6):693-700. PubMed ID: 22648296
[TBL] [Abstract][Full Text] [Related]
45. Impaired vitamin D metabolism in CKD.
Bosworth C; de Boer IH
Semin Nephrol; 2013 Mar; 33(2):158-68. PubMed ID: 23465502
[TBL] [Abstract][Full Text] [Related]
46. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
47. Relationships between Total, Free and Bioavailable Vitamin D and Vitamin D Binding Protein in Early Pregnancy with Neonatal Outcomes: A Retrospective Cohort Study.
Fernando M; Coster TG; Ellery SJ; Guingand D; Lim S; Harrison CL; Teede HJ; Naderpoor N; Mousa A
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32824958
[TBL] [Abstract][Full Text] [Related]
48. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease.
Koenig KG; Lindberg JS; Zerwekh JE; Padalino PK; Cushner HM; Copley JB
Kidney Int; 1992 Jan; 41(1):161-5. PubMed ID: 1593853
[TBL] [Abstract][Full Text] [Related]
49. Serum 25-hydroxyvitamin D level is negatively associated with serum phosphorus level among stage 3a-5 chronic kidney disease patients.
Fayed A; El Nokeety MM; Heikal AA; Marzouk K; Hammad H; Abdulazim DO; Salem MM; Sharaf El Din UA;
Nefrologia (Engl Ed); 2018; 38(5):514-519. PubMed ID: 29843900
[TBL] [Abstract][Full Text] [Related]
50. FGF23 modifies the relationship between vitamin D and cardiac remodeling.
Ky B; Shults J; Keane MG; Sutton MS; Wolf M; Feldman HI; Reese PP; Anderson CA; Townsend RR; Deo R; Lo J; Gadegbeku C; Carlow D; Sulik MJ; Leonard MB;
Circ Heart Fail; 2013 Jul; 6(4):817-24. PubMed ID: 23748358
[TBL] [Abstract][Full Text] [Related]
51. Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites.
Jones KS; Redmond J; Fulford AJ; Jarjou L; Zhou B; Prentice A; Schoenmakers I
J Steroid Biochem Mol Biol; 2017 Sep; 172():130-135. PubMed ID: 28732681
[TBL] [Abstract][Full Text] [Related]
52. Biomarkers of Vitamin D Status and Risk of ESRD.
Rebholz CM; Grams ME; Lutsey PL; Hoofnagle AN; Misialek JR; Inker LA; Levey AS; Selvin E; Hsu CY; Kimmel PL; Vasan RS; Eckfeldt JH; Coresh J;
Am J Kidney Dis; 2016 Feb; 67(2):235-42. PubMed ID: 26475393
[TBL] [Abstract][Full Text] [Related]
53. Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.
Liu D; Alvarez-Elías AC; Wile B; Belostotsky V; Filler G
BMC Nephrol; 2017 Jun; 18(1):204. PubMed ID: 28659167
[TBL] [Abstract][Full Text] [Related]
54. Critically Ill Children Have Low Vitamin D-Binding Protein, Influencing Bioavailability of Vitamin D.
Madden K; Feldman HA; Chun RF; Smith EM; Sullivan RM; Agan AA; Keisling SM; Panoskaltsis-Mortari A; Randolph AG
Ann Am Thorac Soc; 2015 Nov; 12(11):1654-61. PubMed ID: 26356094
[TBL] [Abstract][Full Text] [Related]
55. Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease.
Sakoh T; Nakayama M; Tsuchihashi T; Yoshitomi R; Tanaka S; Katafuchi E; Fukui A; Shikuwa Y; Anzai N; Kitazono T; Tsuruya K
Metabolism; 2016 Oct; 65(10):1498-507. PubMed ID: 27621185
[TBL] [Abstract][Full Text] [Related]
56. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D in chronic kidney disease.
Dusso A; González EA; Martin KJ
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):647-55. PubMed ID: 21872805
[TBL] [Abstract][Full Text] [Related]
58. Vitamin D and DBP: the free hormone hypothesis revisited.
Chun RF; Peercy BE; Orwoll ES; Nielson CM; Adams JS; Hewison M
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():132-7. PubMed ID: 24095930
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast growth factor 23 counters vitamin D metabolism and action in human mesenchymal stem cells.
Meng F; Bertucci C; Gao Y; Li J; Luu S; LeBoff MS; Glowacki J; Zhou S
J Steroid Biochem Mol Biol; 2020 May; 199():105587. PubMed ID: 32004706
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D metabolites in childhood nephrotic syndrome.
Grymonprez A; Proesmans W; Van Dyck M; Jans I; Goos G; Bouillon R
Pediatr Nephrol; 1995 Jun; 9(3):278-81. PubMed ID: 7632510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
